Analysis

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in innovative medicine

Banks Earnings Preview: Top banks set to report Q4 2025 earnings results this week

A number of major banks are set to publish their earnings results for the fourth quarter of 2025 this week. While JPMorgan

Shifting demand and margins in focus as Fastenal (FAST) prepares for Q4 report

Fastenal Company (NASDAQ: FAST) is gearing up to publish its fourth-quarter 2025 financial results, after effectively navigating an evolving market environment. The report

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

Bank of New York Mellon Corporation (BK) Earnings: 4Q25 Key Numbers

The Bank of New York Mellon Corporation (NYSE: BK) reported its fourth quarter 2025 earnings results today. Total revenue of $5.2 billion increased 7% on a year-over-year basis. Net income

January 13, 2026

Delta Air Lines (DAL) Q4 2025 Earnings: Key financials and quarterly highlights

Delta Air Lines (NYSE: DAL) reported its fourth quarter 2025 earnings results today. Total operating revenue increased 3% year-over-year to $16 billion. Net income grew 45% to $1.22 billion, or

January 13, 2026

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in innovative medicine and medical technology. The company continues to expand

January 12, 2026

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top